These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10240436)

  • 21. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 22. Constitutional protection of commercial speech under the Central Hudson test as applied to health claims.
    Schramm MJ
    Food Drug Law J; 1996; 51(2):323-9. PubMed ID: 11822325
    [No Abstract]   [Full Text] [Related]  

  • 23. Kiss and make-up: a need for consolidation of FDA and cosmetic industry regulation programs.
    Mason DE
    Health Matrix Clevel; 2008; 18(1):181-207. PubMed ID: 19161130
    [No Abstract]   [Full Text] [Related]  

  • 24. A global view of the First Amendment constraints of FDA.
    Carver KH
    Food Drug Law J; 2008; 63(1):151-215. PubMed ID: 18561459
    [No Abstract]   [Full Text] [Related]  

  • 25. Food and Drug Administration regulation of tobacco: snatching defeat from the jaws of victory.
    Siegel M
    Tob Control; 2004 Dec; 13(4):439-41. PubMed ID: 15564633
    [No Abstract]   [Full Text] [Related]  

  • 26. Public health. Toward evidence-based health claims for foods.
    Katan MB; de Roos NM
    Science; 2003 Jan; 299(5604):206-7. PubMed ID: 12522235
    [No Abstract]   [Full Text] [Related]  

  • 27. Home care is where the dollars are.
    Woolf T
    Med Mark Media; 1982 Nov; 17(11):84-92. PubMed ID: 10257974
    [No Abstract]   [Full Text] [Related]  

  • 28. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
    Helmanis AM
    Food Drug Law J; 1996; 51(4):631-5. PubMed ID: 11797732
    [No Abstract]   [Full Text] [Related]  

  • 29. Reuser friendly: a review of the regulation of and the product liability regarding the reuse of single-use medical devices.
    Wood JM; Heyman GF
    Tort Insur Law J; 2001; 37(1):41-78. PubMed ID: 11963939
    [No Abstract]   [Full Text] [Related]  

  • 30. Health care, public health, and the food and agriculture critical infrastructures.
    Boddie WS; Kun L
    IEEE Eng Med Biol Mag; 2008; 27(6):54-8. PubMed ID: 19004696
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulation of cosmetics that are also drugs.
    Greff JA
    Food Drug Law J; 1996; 51(2):243-72. PubMed ID: 11820201
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial: limitations of the physicians' desk reference 2007.
    Mindel JS; Teich SA; Teich CM; Beam P
    Surv Ophthalmol; 2008; 53(1):82-4. PubMed ID: 18191659
    [No Abstract]   [Full Text] [Related]  

  • 33. Fifty years of cosmetic safety: a government and industry partnership.
    Donegan TJ
    Food Drug Law J; 1995; 50 Spec():151-62. PubMed ID: 10343040
    [No Abstract]   [Full Text] [Related]  

  • 34. Legal overview of likely FDA regulation of Internet promotion.
    Scheineson MJ
    Food Drug Law J; 1996; 51(4):697-716. PubMed ID: 11797736
    [No Abstract]   [Full Text] [Related]  

  • 35. The case for a substantial evidence amendment to the informal rulemaking provision of the Federal Food, Drug, and Cosmetic Act.
    Bachrach EE
    Food Drug Law J; 2000; 55(3):293-9. PubMed ID: 11824461
    [No Abstract]   [Full Text] [Related]  

  • 36. The First Amendment and federal court deference to the Food and Drug Administration: The Times They Are A-Changin'.
    Basile EM; Gross M
    Food Drug Law J; 2004; 59(1):31-44. PubMed ID: 15190924
    [No Abstract]   [Full Text] [Related]  

  • 37. Beyond food and evil.
    Chen J
    Duke Law J; 2007 Apr; 56(6):1581-6. PubMed ID: 17679180
    [No Abstract]   [Full Text] [Related]  

  • 38. The FDA at work: cutting-edge science promoting public health.
    Hilts PJ
    FDA Consum; 2006; 40(1):28-35, 39-41. PubMed ID: 16528824
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production.
    Karny GM
    Univ Toledo Law Rev; 1981; 12(4):815-68. PubMed ID: 11649588
    [No Abstract]   [Full Text] [Related]  

  • 40. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.